ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides

Hematopoietic stem cell transplantation (HSCT) is a useful treatment. In contrast to solid organ transplantations, the use of ABO blood group mismatch is acceptable in HSCT. Immediate or late hemolytic reactions, pure red cell aplasia, delayed red blood cell recovery, and graft-versus -host disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Shokrgozar, Negin, Tamaddon, Gholamhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375375/
https://www.ncbi.nlm.nih.gov/pubmed/30774834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375375/
https://www.ncbi.nlm.nih.gov/pubmed/30774834

Ejemplares similares